MAAB International Ltd

MAAB International Limited is a family-owned business specialized in investment and international trade of healthcare products. Founded by healthcare industry veterans in 2011, the company relocated its headquarter from Hong Kong to New Zealand in 2020 when the MAAB founders immigrated to Nelson. Outside New Zealand, MAAB has operations in China, Denmark, and UK.

MAAB’s product portfolio consists of two general categories: medical products for hospital and professional use and consumer healthcare products.

MAAB medical products include:

• ClearSky®, a range of intelligent medical device for diagnosing and monitoring neurodegenerative diseases.
• Peptest®, the world’s first non-invasive diagnostic test for reflux.

MAAB consumer healthcare products include:

• MAAB Probiotics®, probiotic OTC drugs and dietary supplements
• PurePang™, alginate-based healthcare products

MAAB is trying to bring these innovative technologies into New Zealand and for that we are keen to work with businesses and healthcare professionals with shared passion to make a difference in patients’ lives.